Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA Approves Hyrimoz for Chronic Conditions

Sandoz news release; 2018 Oct 31

Sandoz has announced that the US Food and Drug Administration (FDA) approved its

biosimilar, Hyrimoz (adalimumab-adaz) for the treatment of rheumatoid

arthritis (RA), juvenile idiopathic arthritis (JIA) in patients ≥4 years, psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn’s disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps).

Sandoz, a Novartis division, is headquartered in Holzkirchen, Germany.

Dosage/administration: Hyrimoz is administered by injection: 40 mg/0.8 mL in a single-dose pre-filled glass syringe (with BD UltraSafe Passive Needle Guard) or injection: 40 mg/0.8 mL in a single-dose pre-filled pen (Sensoready Pen). For full dosage/administration information, visit:

Adverse reactions: The most common adverse reactions (incidence > 10 %) are infections (eg upper respiratory, sinusitis), injection site reactions, headache, and rash.


Sandoz receives US FDA approval for biosimilar Hyrimoz (adalimumab-adaz). [news release]. Holzkirchen, Germany: Sandoz. October 31, 2018. Accessed November 8, 2018.

This Week's Must Reads

TNF inhibitor prices rose despite increased drug class competition, San-Juan-Rodriguez A et al. JAMA Intern Med. 2019 Feb 18. doi: 10.1001/jamainternmed.2018.7656

List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598

Examining Brain Correlates of Clinical Pain in RA, Arthritis Care Res; 2019 Feb; Lee, Fine, et al

Obesity/Weight Loss Linked to Mortality Risk in RA, Clin Exp Rheumatol; ePub 2019 Jan 18; Baker, et al

Study Does Not Back MRI-Guided Treatment Strategy, JAMA; ePub 2019 Feb 5; Møller-Bisgaard, et al

Must Reads in Ankylosing spondylitis

FDA Approves Hyrimoz for Chronic Conditions, Sandoz news release; 2018 Oct 31

Increase in Knee, Hip Arthroplasties Found in AS, J Rheumatol; ePub 2018 Jul; Ward

FDA Approves New Pfizer Biosimilar Ixifi, Pfizer news release; 2017 Dec 13

AS Pain May Derive from Spinal Inflammation Alone, J Rheumatol; ePub 2017 Dec 1; Dau, Lee, Ward, et al

Geographic Distance Affects DMARD Use for Veterans, J Rheumatol; ePub 2017 Nov 15; Walsh, Pei, et al